Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases

Biomolecules - Switzerland
doi 10.3390/biom10030389
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Galectin‐3 as a Candidate Upstream Biomarker for Quantifying Risks of Myocardial Ageing

ESC heart failure
Cardiovascular MedicineCardiology
2019English

Next-Generation Phenotypic Screening in Early Drug Discovery for Infectious Diseases

Trends in Parasitology
ParasitologyInfectious Diseases
2019English

A Computational Cognitive Biomarker for Early-Stage Huntington’s Disease

PLoS ONE
Multidisciplinary
2016English

P2.03-07 Radiomic Signatures Linked to Genetic Alterations as Detected by Next-Generation Sequencing: A Radiogenomics Analysis of Early-Stage NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

A New Approach for Detecting Low-Level Mutations in Next-Generation Sequence Data

Genome Biology
2012English

Systemic miRNA-195 Differentiates Breast Cancer From Other Malignancies and Is a Potential Biomarker for Detecting Noninvasive and Early Stage Disease

Oncologist
Cancer ResearchMedicineOncology
2010English

The Next Generation of Biomarker Research in Spinal Cord Injury

Molecular Neurobiology
NeuroscienceNeurologyCellularMolecular Neuroscience
2016English

ThX – A Next-Generation Probe for the Early Detection of Amyloid Aggregates

Chemical Science
Chemistry
2020English

Soluble Endoglin (sCD105) as a Novel Biomarker for Detecting Aggressive Prostate Cancer

Anticancer Research
MedicineCancer ResearchOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy